Repaglinide is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Repaglinide.
Product ID | 63629-9194_20842ef2-0622-440b-b590-1d40af18c602 |
NDC | 63629-9194 |
Product Type | Human Prescription Drug |
Proprietary Name | Repaglinide |
Generic Name | Repaglinide |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2014-01-22 |
Marketing Category | ANDA / |
Application Number | ANDA201189 |
Labeler Name | Bryant Ranch Prepack |
Substance Name | REPAGLINIDE |
Active Ingredient Strength | 2 mg/1 |
Pharm Classes | Glinide [EPC], Potassium Channel Antagonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-08-03 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0378-3122 | Repaglinide | repaglinide |
0378-3123 | Repaglinide | repaglinide |
0574-0240 | Repaglinide | REPAGLINIDE |
0574-0241 | Repaglinide | REPAGLINIDE |
0574-0242 | Repaglinide | REPAGLINIDE |
51079-539 | Repaglinide | repaglinide |
51991-853 | REPAGLINIDE | REPAGLINIDE |
51991-854 | REPAGLINIDE | REPAGLINIDE |
51991-855 | REPAGLINIDE | REPAGLINIDE |
57237-157 | Repaglinide | Repaglinide |
57237-158 | Repaglinide | Repaglinide |
57237-159 | Repaglinide | Repaglinide |
57664-745 | Repaglinide | Repaglinide |
57664-747 | Repaglinide | Repaglinide |
60429-484 | REPAGLINIDE | REPAGLINIDE |
60429-485 | REPAGLINIDE | REPAGLINIDE |
60429-486 | REPAGLINIDE | REPAGLINIDE |
68084-967 | Repaglinide | Repaglinide |
68084-954 | Repaglinide | Repaglinide |
65862-670 | Repaglinide | Repaglinide |
65862-671 | Repaglinide | Repaglinide |
65862-672 | Repaglinide | Repaglinide |
0169-0081 | Prandin | repaglinide |
0169-0082 | Prandin | repaglinide |
0169-0084 | Prandin | repaglinide |